OPCH insiders

20 insiders have filed at OPCH since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Rademacher John CharlesChief Executive Officer682.7k0.431%
Kraemer Harry M Jansen JRDirector413.4k0.261%5 buys $5.9M
Shapiro Michael H.Chief Financial Officer311.9k0.197%1 sells $719k
Whitworth LukeChief Operating Officer169.6k0.107%
Golding David WDirector116.5k0.074%1 buys $28k
Sethna MeenalChief Financial Officer82.1k0.052%
Smyser CollinGc & Corporate Secretary77.1k0.049%1 buys $87k
Arlotta JohnDirector71.0k0.045%
Sullivan Timothy PDirector49.2k0.031%1 buys $550k1 sells $1.5M
Grashoff Christopher L.Chief Growth Officer44.1k0.028%
Bavaro MichaelChief Human Resources Officer33.2k0.021%4 sells $1.5M
Betten Elizabeth QuadrosDirector29.2k0.018%1 sells $1.5M
Maggio NicoleChief Accounting Officer28.5k0.018%
Adewunmi FemiChief Medical Officer26.7k0.017%
Bierbower Elizabeth DDirector23.9k0.015%1 buys $79k
Deckmann NatashaDirector22.2k0.014%
Wright Norman L.Director15.5k0.01%1 buys $100k
Bodem Barbara W.Director12.1k<0.01%
Pate R CarterDirector11.6k<0.01%2 buys $71k2 sells $1.0M
Brandt EricDirector10.4k<0.01%

Full register at boothcheck.com/insiders/OPCH. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

OPCH institutional holders · OPCH research report